JF
Jessica Baker Flechtner
Chief Scientific Officer

Jessica Baker Flechtner insider trades: Genocea Biosciences (GNCA) stock sales

Chief Scientific Officer, Genocea Biosciences Last trade Jun 2, 2022 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2014
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jessica reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 2, 2022GNCA↓ Sell$95
May 25, 2022GNCA↓ Sell$1K
Apr 4, 2022GNCA↓ Sell$2K
Mar 16, 2022GNCA↓ Sell$4K
Sep 1, 2015GNCA↓ Sell$25K
Aug 3, 2015GNCA↓ Sell$29K
Jul 1, 2015GNCA↓ Sell$31K
Jun 1, 2015GNCA↓ Sell$23K
May 1, 2015GNCA↓ Sell$23K
Apr 1, 2015GNCA↓ Sell$27K
Mar 2, 2015GNCA↓ Sell$32K
Feb 2, 2015GNCA↓ Sell$40K
Sep 12, 2014GNCA↓ Sell$77K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jessica Baker Flechtner's insider trades

Jessica Baker Flechtner is Chief Scientific Officer at Genocea Biosciences (GNCA). Since Sep 12, 2014, Jessica has reported no open-market purchases and 13 sales worth $314K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), option exercises (11 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GNCA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.